DOCSLIB.ORG

COVID-19, Maternal and Child Health, Nutrition – Literature Repository April 2021

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
COVID-19, Maternal and Child Health, Nutrition – Literature Repository April 2021 COVID-19, Maternal and Child Health, Nutrition – Literature Repository April 2021 Key Terms Date Title Journal / Source Type of Summary & Key Points Specific Observations Full Citation Published Publication This represents the final version (updated 30 April, 2021). New publications since our last update have been highlighted in blue. COVID-19; 29-Apr-21 A COVID-19- Pediatric Letter to The authors described the case of a SARS-CoV-2-positive infant in The authors described the case Pierre L, Kondamudi N, pediatric; Positive Infant Emergency Care the Editor the United States presenting with sudden cardiac arrest [date not of a SARS-CoV-2-positive infant Adeyinka A, et al. A COVID-19- cardiac arrest; Presenting With specified]. The 36-day-old infant was found unresponsive and not in the United States presenting Positive Infant Presenting With United States Sudden Cardiac breathing, and emergency medical services were called. Cardio- with sudden cardiac arrest. Sudden Cardiac Arrest. Pediatr Arrest pulmonary resuscitation, including endotracheal intubation, The infant manifested a robust Emerg Care. 2021;37(5):e280- ventilation, and intra-osseous access, was initiated in the field. The inflammatory response which e281. spontaneous return of circulation was accomplished in is suggestive of MIS-C, but with doi:10.1097/PEC.00000000000 approximately 5 min. The patient was asymptomatic before the absence of fever and skin 02432. onset of this catastrophic event and with no bacterial pathogen rashes. detected in the initial workup. The infant manifested a robust inflammatory response evidenced by high white blood cell count, elevated C-reactive protein, abnormal coagulation, elevated D- dimer levels, low fibrinogen, elevated ferritin, and positive SARS- CoV-2 IgG antibody. This clinical picture is suggestive of MIS-C, but fever and skin rashes were absent. Chest X-ray showed normal lungs without any cardiomegaly. Echocardiogram revealed reduced left ventricular function with a shortening fraction of 18% to 20% and an ejection fraction of 36% to 40%. There was mild mitral regurgitation without ventricular dilatation and no identifiable structural heart defects. This article demonstrates a case of COVID- 19 presenting with sudden cardiac arrest in a child. COVID-19; 29-Apr-21 An autopsy study EClinicalMedicine Case Series The authors described the pathology findings in 5 children and The authors described the Duarte-Neto AN, Caldini EG, pediatric; MIS- of the spectrum of adolescents (age range=7 months-15 years) who died with SARS- pathology findings in 5 Gomes-Gouvêa MS, et al. An C; autopsy; severe COVID-19 CoV-2 infection in Brazil between 18 March-15 August 2020. Tissue children and adolescents who autopsy study of the spectrum pathology; in children: From samples from vital organs (lungs, heart, brain, kidneys, liver, and died with SARS-CoV-2 infection of severe COVID-19 in children: Brazil SARS to different spleen) were analyzed by histology, electron microscopy (EM), RT- in Brazil between 18 March-15 From SARS to different phenotypes of PCR and immunohistochemistry (IHC). 2 patients had other severe August 2020. In all patients, phenotypes of MIS-C. MIS-C diseases previous to SARS-CoV-2 infection: 1 adolescent with SARS-CoV-2 was detected in EClinicalMedicine. adrenal carcinoma, who had diffuse alveolar damage (DAD) and lungs, heart, and kidneys by at 2021;35:100850. thrombotic events, and 1 infant with Edwards syndrome, with least one method (RT-PCR, IHC doi:10.1016/j.eclinm.2021.100 severe COVID-19-related pneumonia, DAD, and syncytial giant cell or EM) and in endothelial cells 850. hepatitis attributed to SARS-CoV-2 infection. The other 3 patients from heart and brain in 2 fulfilled the criteria for MIS-C with extrapulmonary manifestations patients with MIS-C (IHC). In attributed to SARS-CoV-2 infection (myocarditis, colitis, and acute addition, the study revealed encephalopathy with status epilepticus). Autopsy findings varied for the first time the presence amongst patients and included mild to severe COVID-19 of SARS-CoV-2 in the brain pneumonia, pulmonary micro-thrombosis, cerebral oedema with tissue of a child with MIS-C reactive gliosis, myocarditis, intestinal inflammation, and with acute encephalopathy, haemophagocytosis. SARS-CoV-2 RNA, antigens and virions were and in the intestinal tissue of a detected in several tissues by RT-PCR, IHC and EM, respectively. In child with acute colitis. all patients, SARS-CoV-2 was detected in lungs, heart, and kidneys by at least one method (RT-PCR, IHC or EM) and in endothelial cells from heart and brain in 2 patients with MIS-C (IHC). In addition, the study revealed for the first time the presence of SARS-CoV-2 in the brain tissue of a child with MIS-C with acute encephalopathy, and 1 COVID-19, Maternal and Child Health, Nutrition – Literature Repository April 2021 Key Terms Date Title Journal / Source Type of Summary & Key Points Specific Observations Full Citation Published Publication in the intestinal tissue of a child with acute colitis. The presence of SARS-CoV-2 in several organs, associated with cellular ultrastructural changes, reinforces the hypothesis that a direct effect of SARS-CoV-2 on tissues is involved in the pathogenesis of MIS-C. COVID-19; 28-Apr-21 Acute parotitis in Journal of Brief The authors described a case of acute parotitis in a 4‐year‐old The authors described a rare Ekemen Keles Y, Karadag Oncel pediatric; acute a 4-year-old in Paediatrics and Communic patient with COVID‐19 in Turkey. The 4‐year‐old male presented case of acute parotitis in a 4‐ E, Baysal M, et al. Acute parotitis; association with Child Health ation with a day of malaise, diarrhea, vomiting and mild abdominal pain. year‐old patient with COVID‐ parotitis in a 4-year-old in Turkey COVID-19 His parents tested positive for SARS-CoV-2 by RT-PCR one day 19 in Turkey. The patient was association with COVID-19. J earlier. At presentation, the patient was hemodynamically stable treated with a non‐steroidal Paediatr Child Health. 2021. with a completely normal physical examination. A combined anti‐inflammatory for 3 days, doi:10.1111/jpc.15527. oropharyngeal and nasopharyngeal swab was positive for SARS‐ after which the facial swelling CoV‐2 by RT-PCR. 4 days later, he was admitted with right‐sided resolved. facial swelling and pain, especially in the pre‐auricular area and cheek, with difficulty swallowing. The swelling measured 2 × 2 cm, extended from the pre‐auricular region to the mandible, and was soft and non‐fluctuant. There was no purulent discharge after parotid massage. Other systems examinations were normal. Neck ultrasonography showed diffuse, hypoechoic enlargement of the parotid gland, compatible with acute parotitis. No pathological lymphadenopathy was detected. The patient was treated with a non‐steroidal anti‐inflammatory agent. At follow‐up, 3 days later, his facial swelling had resolved. This case highlights the rare occurrence of COVID‐19‐associated parotitis in children. COVID-19; 28-Apr-21 Stroke in a child eNeurologicalSci Case The authors described a case of stroke in a pediatric patient with The authors described a case Khosravia B, Moradvaesib B, pediatric; with SARS-CoV-2 Report SARS-CoV-2 infection in Iran [date not specified]. The 10-year-old of stroke in a pediatric patient Abedini M, et al. Stroke in a stroke; Iran infection: A case female had a severe headache in the right temporal area followed with SARS-CoV-2 infection in child with SARS-CoV-2 report by facial distortion, tonic movements of the shoulders and the Iran. Enoxaparin was infection: A case report. right leg, and loss of consciousness for 5 min. She was hospitalized prescribed until lack of eNeurologicalSci. 2021. due to the seizures and tested positive for SARS-CoV-2 by thrombosis was confirmed doi:10.1016/j.ensci.2021.1003 nasopharyngeal RT-PCR. One week before, she had had a low- (5 days), followed by aspirin 45. grade fever and gastro-intestinal manifestations such as vomiting treatment. According to this and abdominal pain for 2 days. She had no previous history of case report, SARS-CoV-2 cough, shortness of breath, skin rash, or recent trauma. Acute infection may contribute to infarction was seen in the right putamen, globus pallidus, and the the occurrence and posterior part of the insula. A small focal dilatation within M1 development of ischemic segment of the left middle cerebral artery (MCA) was also stroke in children. observed. Enoxaparin was prescribed until lack of thrombosis was confirmed (5 days), followed by aspirin treatment. According to this case report, SARS-CoV-2 infection may contribute to the occurrence and development of ischemic stroke in children. 2 COVID-19, Maternal and Child Health, Nutrition – Literature Repository April 2021 Key Terms Date Title Journal / Source Type of Summary & Key Points Specific Observations Full Citation Published Publication COVID-19; 28-Apr-21 Can Hematological Turkish Journal of Letter to The authors conducted a retrospective study at a children’s In their hematological findings, Ötiken Arıkan K, Şahinkaya Ş, hematology; Findings of COVID- Hematology the Editor hospital in Izmir, Turkey, between 30 March-31 October 2020 to the authors found that the Böncüoğlu E, et al. Can pediatric 19 in Pediatric assess pediatric hematological findings. 9.1% (n=353) of the lymphocyte to white blood cell Hematological Findings of COVID-19 Patients Guide pediatric patients tested were diagnosed with COVID-19, 52.1% ratio was lower and the COVID-19 in Pediatric Patients Physicians about (n=184) of whom were male and the median age in the SARS-CoV- neutrophil-to-lymphocyte ratio Guide Physicians about Clinical Clinical Severity? 2 positive cohort was 9 years (range: 4 days-17 years). 2.5% (n=9), was higher in severe/critical Severity? [published online 83% (n=293), 10.8% (n=38) and 3.7& (n=13) cases were diagnosed cases of COVID-19 compared ahead of print, 2021 Apr 28].
Load more

Recommended publications
  • Introduction of Inactivated Poliovirus Vaccine and Impact on Vaccine- Associated Paralytic Poliomyelitis — Beijing, China, 2014–2016
    Morbidity and Mortality Weekly Report Introduction of Inactivated Poliovirus Vaccine and Impact on Vaccine- Associated Paralytic Poliomyelitis — Beijing, China, 2014–2016 Dan Zhao, MD1; Rui Ma, MD1; Tao Zhou, MD1; Fan Yang, MD1; Jin Wu, MD2; Hao Sun3; Fang Liu, MD4; Li Lu, MD1; Xiaomei Li1; Shuyan Zuo, MD5; Wei Yao6; JianYin6 When included in a sequential polio vaccination schedule, the risk for VAPP associated with subsequent OPV doses. inactivated polio vaccine (IPV) reduces the risk for vaccine- Countries that have previously introduced at least 1 IPV dose associated paralytic poliomyelitis (VAPP), a rare adverse event before vaccination with OPV have rapidly eliminated VAPP associated with receipt of oral poliovirus vaccine (OPV). (1). IPV has been available in China’s private sector since During January 2014, the World Health Organization (WHO) 2009. After completion of immunogenicity studies (3–5), recommended introduction of at least 1 IPV dose into routine Beijing introduced IPV into the public sector EPI program in immunization schedules in OPV-using countries (1). The December 2014 as part of a sequential schedule that included Polio Eradication and Endgame Strategic Plan 2013–2018 1 dose of IPV at age 2 months, followed by 3 doses of trivalent recommended completion of IPV introduction in 2015 and OPV at ages 3, 4, and 48 months. After the global synchronized globally synchronized withdrawal of OPV type 2 in 2016 (2). withdrawal of all Sabin type 2 vaccines in April 2016, trivalent Introduction of 1 dose of IPV into Beijing’s Expanded Program OPV was replaced with bivalent OPV, which contains types 1 on Immunization (EPI) on December 5, 2014 represented and 3 oral polio vaccine viruses.
    [Show full text]
  • Valuing the Cost of Improving Chilean Primary Vaccination: a Cost Minimization Analysis of a Hexavalent Vaccine
    Olivera et al. BMC Health Services Research (2020) 20:295 https://doi.org/10.1186/s12913-020-05115-7 RESEARCH ARTICLE Open Access Valuing the cost of improving Chilean primary vaccination: a cost minimization analysis of a hexavalent vaccine Ignacio Olivera1, Carlos Grau1, Hugo Dibarboure2, Juan Pablo Torres3, Gustavo Mieres1, Luis Lazarov1, Fabián P. Alvarez4 and Juan Guillermo López Yescas5* Abstract Background: The phased withdrawal of oral polio vaccine (OPV) and the introduction of inactivated poliovirus vaccine (IPV) is central to the polio ‘end-game’ strategy. Methods: We analyzed the cost implications in Chile of a switch from the vaccination scheme consisting of a pentavalent vaccine with whole-cell pertussis component (wP) plus IPV/OPV vaccines to a scheme with a hexavalent vaccine with acellular pertussis component (aP) and IPV (Hexaxim®) from a societal perspective. Cost data were collected from a variety of sources including national estimates and previous vaccine studies. All costs were expressed in 2017 prices (US$ 1.00 = $Ch 666.26). Results: The overall costs associated with the vaccination scheme (4 doses of pentavalent vaccine plus 1 dose IPV and 3 doses OPV) from a societal perspective was estimated to be US$ 12.70 million, of which US$ 8.84 million were associated with the management of adverse events related to wP. In comparison, the cost associated with the 4-dose scheme with a hexavalent vaccine (based upon the PAHO reference price) was US$ 19.76 million. The cost of switching to the hexavalent vaccine would be an additional US$ 6.45 million. Overall, depending on the scenario, the costs of switching to the hexavalent scheme would range from an additional US$ 2.62 million to US$ 6.45 million compared with the current vaccination scheme.
    [Show full text]
  • X-Ray Interpretation
    Objectives Describe a systematic method for interpretation of chest and abdomen x-rays List findings to accurately identify common X-ray Interpretation pathology in chest & abdomen x-rays Describe a systematic method to approach the Denise Ramponi, DNP, FNP-C, ENP-BC, FAANP, FAEN important components in interpretation of upper & lower extremity x-rays Chest X-ray: Standard Views Lateral Film Postero-anterior (PA): (LAT) view can determine th On inspiration – diaphragm descends to 10 rib the anterior-posterior posteriorly structures along the axis of the body Normal LAT film Counting Ribs AP View - Portable http://www.lumen.luc.edu/lumen/MedEd/medicine/pulmonar/cxr/cxr_f.htm When the patient is unable to tolerate routine views with pts sitting or supine No participation from the patient Film is against the patient's back (supine) 1 Consolidation, Atelectasis, Chest radiograph Interstitial involvement Consolidation - any pathologic process that fills the alveoli with Left and right heart fluid, pus, blood, cells or other borders well defined substances Interstitial - involvement of the Both hemidiaphragms supporting tissue of the lung visible to midline parenchyma resulting in fine or coarse reticular opacities Right - higher Atelectasis - collapse of a part of Heart less than 50% of the lung due to a decrease in the amount of air resulting in volume diameter of the chest loss and increased density. Infiltrate, Consolidation vs. Congestive Heart Failure Atelectasis Fluid leaking into interstitium Kerley B 2 Kerley B lines Prominent interstitial markings Kerley lines Magnified CXR Cardiomyopathy & interstitial pulmonary edema Short 1-2 cm white lines at lung periphery horizontal to pleural surface Distended interlobular septa - secondary to interstitial edema.
    [Show full text]
  • The Hepatitis B Vaccine Is the Most Widely Used Vaccine in the World, with Over 1 Billion Doses Given
    Hepatitis B Vaccine Protect Yourself and Those You Love What is Hepatitis B? Hepatitis B is the most common serious liver infection in the world. It is caused by the hepatitis B virus (HBV), which attacks liver cells and can lead to liver failure, cirrhosis (scarring), or liver cancer later in life. The virus is transmitted through direct contact with infected blood and bodily fluids, and from an infected woman to her newborn at birth. Is there a safe vaccine for hepatitis B? YES! The good news is that there is a safe and effective vaccine for hepatitis B. The vaccine is a series, typically given as three shots over a six-month period that will provide a lifetime of protection. You cannot get hepatitis B from the vaccine – there is no human blood or live virus in the vaccine. The hepatitis B vaccine is the most widely used vaccine in the world, with over 1 billion doses given. The hepatitis B vaccine is the first "anti-cancer" vaccine because it can help prevent liver cancer! Who should be vaccinated against hepatitis B? The World Health Organization (WHO) and the U.S. Centers for Disease Control and Prevention (CDC) recommend the hepatitis B vaccine for all newborns and children up to 18 years of age, and all high-risk adults. All infants should receive the first dose of the vaccine in the delivery room or in the first 24 hours of life, preferably within 12 hours. (CDC recommends the first dose within 12 hours vs. the WHO recommendation of 24 hours.) The HBV vaccine is recommended to anyone who is at high risk of infection.
    [Show full text]
  • (DTP-Hep B-Hib) Vaccine Into the EPI Programme
    EPIDEMIOLOGICAL UNIT Department of Health Services Ministry of Health Care and Nutrition 231, de Saram Place, Colombo 01000, Sri Lanka Telephone: (+94-11-) 2681548, 2695112, Fax: (+94-11-) 2696583, E-mail: [email protected], [email protected] My No: EPI/81/VII/2007 22nd October 2007 Provincial /Regional Directors of Health Services, Directors of Teaching Hospitals/Specialized Campaigns, M. SS /D.M.OO of Provincial /Base Hospitals, Heads of Decentralized Units and, Medical Officers of Health Introduction of combined pentavalent (DTP-Hep B- Hib) Vaccine into the EPI A decision has been taken to introduce Hib (Haemophilus Influenzae B) vaccine into the EPI programme in Sri Lanka from year 2008. This decision is based on the recommendation by the National Advisory Committee on Communicable Diseases. The Hib vaccine will be in the form of a combined pentavalent (DTP-HepB-Hib) vaccine, which would include DTP and Hep B and therefore would replace both DTP and Hepatitis B in the present schedule. Background The bacterium, Haemophilus influenzae type B (Hib), is an important cause of infections in infants and young children; severe disease in adults due to Hib is uncommon. Where it has been studied carefully, Hib is the leading cause of acute bacterial meningitis in infants and children less than five years old, accounting for one-third to one-half of all cases of bacterial meningitis in this age group. Bacterial meningitis is fatal unless treated immediately with antibiotics. Even with proper treatment 3-25% of affected children may die. Permanent disability with sequelae that include deafness, learning disabilities, and difficulties in movement is not uncommon among those who survive the infection.
    [Show full text]
  • Pentavalent and Hexavalent Vaccines
    Pentavalent and Hexavalent Vaccines Cold Chain Equipment Database ID 3_7 Year 2004 The freeze indicator is used to warn of freezing and is packed with vaccines that are sensitive to freezing temperatures: DTP, TT, DT, Td (freezing point of -6.5°C), hepatitis B (-0.5°C), liquid Hib and their combinations (DTP-HepB, and DTP-HepB+Hib vaccines) and JE. Every refrigerator storing vaccines should have a freeze indicator (Freeze Watch™). It is strongly recommended that one freeze indicator be placed in each cold box during vaccine transport and distribution. This is critical in places subject to low temperatures. Immunization in practice: a practical resource guide for Health workers – 2004 update_____Module 3: The cold chain WHO/IVB/04.06 Page 13 Vaccine Handling Database ID 81_1 Year 2006 The recommended conditions for storing vaccines used in immunization programmes are shown in Appendix 81_1. This diagram also indicates the maximum times and temperatures in each case. At the higher levels of the cold chain, i.e., at national (primary), and regional or province level, OPV must be kept frozen between - 15oC and -25oC. Freeze-dried vaccines (i.e., BCG, measles, MMR and yellow fever) may also be kept frozen at -15oC to -25oC if cold chain space permits, but this is neither essential nor recommended. At other levels of the cold chain (intermediate vaccine stores and health facilities), these vaccines should be stored between +2oC and +8oC. All other vaccines should be stored at between +2oC and +8oC at all levels of the cold chain. Liquid formulations of vaccines containing diphtheria, pertussis, tetanus, hepatitis B, Haemophilus influenzae type b, IPV and their combinations should not be frozen.
    [Show full text]
  • Upper Airway Obstruction in Children: Imaging Essentials
    Acute upper airway obstruction in children: Imaging essentials Carlos J. Sivit MD Rainbow Babies and Children’s Hospital Case Western Reserve School of Medicine ►Clinical perspective ►Infections ►Foreign body ►Masses 1 Clinical Clinical ► Common cause of respiratory failure in children ► Potentially life-threatening in younger children because of smaller airway diameter ► Narrowing of upper airway has exponential effect on airflow 2 Clinical ► Majority of children are otherwise healthy ► Appropriate management results in good outcomes ► Improper management has dire consequences ► Imaging plays critical role in diagnosis Clinical ► Signs and symptoms § Respiratory distress § Dysphagia § Odynophagia § Stridor § Absence of air entry § Tachycardia 3 Stridor ► Harsh respiratory noise caused by turbulent air flow through narrowed airway ► Specific for severe upper airway obstruction ► Intensifies in inspiration ► Does not help specify nature or location Infections 4 Infections ► Acute laryngotracheobronchitis ► Acute epiglottitis ► Acute bacterial tracheitis ► Retropharyngeal abscess ► Infectious mononucleosis Croup ► Heterogenous group of acute infections characterized by brassy “croupy” cough ► May or may not be accompanied by stridor, hoarseness and respiratory distress ► Typically seen in younger children § 6 months – 5 years 5 Croup ► Parainfluenza viruses account for 75% ► Adenoviruses, RSV, influenza and measles cause most remaining cases ► Secondary bacterial infection is rare Imaging ►Imaging § Performed to exclude other conditions
    [Show full text]
  • Since January 2020 Elsevier Has Created a COVID-19 Resource Centre with Free Information in English and Mandarin on the Novel Coronavirus COVID- 19
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by IUPUIScholarWorks Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID- 19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. A02842_052 4/11/06 3:59 PM Page 813 Chapter 52 Otolaryngologic Disorders William P. Potsic and Ralph F. Wetmore EAR vibrating tympanic membrane to the stapes footplate. Anatomy Stapes movement creates a fluid wave in the inner ear that travels to the round window membrane and is dissi- The ear is divided into three anatomic and functional pated by reciprocal motion to the stapes. areas: the external ear, the middle ear, and the inner ear. There are two striated muscles in the middle ear. The The external ear consists of the auricle, external auditory tensor tympani muscle lies along the side of the eustachian canal, and the lateral surface of the tympanic membrane. tube, and its tendon attaches to the medial surface of the The auricle is a complex fibroelastic skeleton that is cov- malleus.
    [Show full text]
  • Shaping the Market: Gavi's Model for Bringing the Power of Vaccines To
    #GaviSeth Shaping the market: Gavi’s model for bringing the power of vaccines to the world’s poorest children Seth Berkley MD National Vaccine Advisory Committee 2 February 2015, Washington DC www.gavi.org The challenge: Reducing delays in launching new vaccines in poor countries 2 #vaccineswork Gavi: an innovative public-private partnership Building on the comparative advantages of both public and private partners 3 #vaccineswork Gavi-supported vaccination programmes: an overview Refers to the first Gavi-supported introduction of each vaccine. Vaccine Investment Strategy: Gavi’s approach to prioritsing new vaccines Category VIS Criteria • Cholera Impact on child mortality Health Impact on overall mortality • Dengue impact • Hepatitis A Impact on overall morbidity • Hepatitis B (birth dose) Epidemic potential Global or regional public health priority • Hepatitis E Herd immunity Additional • Influenza* impact Availability of alternative interventions considerations • Meningococcal CYW Socio-economic inequity • Malaria Gender inequity • Rabies Disease of regional importance • Yellow Fever** Capacity and supplier base • DTP booster GAVI market shaping potential Implementation Ease of supply chain integration • Enterovirus 71 feasibility • Mumps Ease of programmatic integration Vaccine efficacy and safety * Maternal vaccination Vaccine procurement cost Cost and value ** Additional mass campaigns In-country operational cost for money Procurement cost per event averted Gavi’s unusual development model Co-financing Market- shaping Donor base
    [Show full text]
  • Cuban Experience in Immunization, 1962–2016*
    Pan American Journal Special report of Public Health Cuban experience in immunization, 1962–2016* Lena López Ambrón,1,2 Liudmila Ibelin Egües Torres,1 Alina Pérez Carreras,3 Belkys María Galindo Santana,4 Miguel Ángel Galindo Sardiña,1 Sonia Resik Aguirre5 and Alina Tejeda Fuentes6 Suggested citation (original manuscript) López Ambrón L, Egües Torres LI, Pérez Carreras A, Galindo Santana BM, Galindo Sardiña MA, Resik Aguirre S, et al. Experiencia cubana en inmunización, 1962–2016. Rev Panam Salud Publica. 2018;42:e34. https://doi.org/10.26633/RPSP.2018.34 ABSTRACT Cuba’s Immunization Program was created in 1962. It arose from the political, economic and social transformations initiated in 1959 when communicable diseases—including vaccine-pre- ventable diseases—were the main cause of child morbidity and mortality. The program’s organi- zation and uninterrupted implementation have led to the eradication of six diseases, two severe clinical forms and two serious complications, as well as incidence and mortality rates of remaining diseases maintained at such low levels they do not constitute a health problem. An average of 4.8 million doses of simple or combined vaccines that protect against 13 diseases are administered annually in Cuba, including a pentavalent vaccine whose five components are produced domesti- cally. The 1962 oral polio vaccine campaign was the first intersectoral experience with community participation in the Americas region, and Cuba was the first country to eradicate the disease. Recent Cuban research results have influenced the Global Polio Eradication Initiative. Universal vaccination against hepatitis B administered 24 hours after birth, using a domestic vaccine, was achieved in Cuba 19 years before the World Health Organization set the goal.
    [Show full text]
  • Sector Assessment (Summary): Vaccines
    Responsive COVID-19 Vaccines for Recovery Project Under the Asia Pacific Vaccine Access Facility (RRP BAN 55077-001) SECTOR ASSESSMENT (SUMMARY): VACCINES A. Sector Road Map 1. Sector Performance, Problems, and Opportunities. 1. Bangladesh has achieved impressive improvements in health service coverage and health outcomes since independence in 1971. In the last 50 years from 2020, life expectancy at birth rose from 44 to 72 years,1 while the under-5 mortality rate declined almost tenfold in the same period (from 239.68 to 28.95 deaths per 1,000 live births).2 Since its establishment in 1974, the Expanded Programme on Immunization (EPI) has achieved notable success, including: (i) the delivery of high levels of coverage against vaccine-preventable diseases,3 with the proportion of children that are fully vaccinated rising from 2% in 1985 to 82.3% in 2016,4 and (ii) the eradication of smallpox and poliomyelitis. In line with regional (Southeast Asia Regional Vaccine Action Plan) and global targets (Global Vaccine Action Plan), the EPI has successfully introduced and scaled several new vaccines to high coverage levels, including the hepatitis B,5 rotavirus (not scaled yet),6 measles-rubella,7 and pneumococcal conjugate vaccines.8 2. Development problems. Equity in access and resource limitations are among key development problems highlighted here. Routine vaccination coverage is high in Bangladesh (at ≥97% nationally in 2019)9 though unevenly distributed across geographic and socio-economic groups, with coverage as low as 78% among children in Dhaka slums (footnote 4), and with coverage increasing according to income and educational attainment.10 The coronavirus disease (COVID-19) vaccination program will need to prioritize these hard-to-reach groups to ensure equitable distribution.
    [Show full text]
  • Comité Consultatif Mondial De La Sécurité
    2013, 88, 301–312 No. 29 Weekly epidemiological record Relevé épidémiologique hebdomadaire 19 JULY 2013, 88th YEAR / 19 JUILLET 2013, 88e ANNÉE No. 29, 2013, 88, 301–312 http://www.who.int/wer Contents Global Advisory Committee Comité consultatif mondial 301 Global Advisory Committee on Vaccine Safety, de la Sécurité vaccinale, on Vaccine Safety, 12–13 June 2013 12–13 June 2013 12-13 juin 2013 The Global Advisory Committee on Vac- Le Comité consultatif mondial de la Sécurité cine Safety (GACVS), an expert clinical vaccinale (GACVS), composé d’experts Sommaire and scientific advisory body, was estab- cliniques et scientifiques, a été créé par l’OMS 301 Comité consultatif mondial lished by WHO to provide independent pour la conseiller, en toute indépendance et de la Sécurité vaccinale, scientifically rigourous advice on vaccine avec la rigueur scientifique voulue, sur des 12-13 juin 2013 safety issues of potential global impor- problèmes de sécurité vaccinale pouvant avoir tance.1 GACVS held its 28th meeting in une importance mondiale.1 Le GACVS a tenu Geneva, Switzerland, on 12–13 June 2013.2 sa 28e réunion à Genève (Suisse), les 12 et The committee reviewed 7 specific issues: 13 juin 2013.2 Il a examiné 7 questions spéci- (i) the experience of 4 Asian countries fiques: 1) l’expérience de 4 pays d’Asie dans with the use of Hib-containing pentavalent l’utilisation du vaccin pentavalent contenant vaccine; (ii) the safety profile of varicella la valence Haemophilus influenzae type b vaccines; (iii) the safety of immunization (Hib); 2) le
    [Show full text]